USP37 and neoplasm: Notably, oxidative phosphorylation, myogenesis, and allograft rejection pathways show a negative correlation with USP37 expression across most tumor types, while its expression is positively associated with the mitotic spindle, G2M checkpoint, and E2F target pathways.